The purpose of this policy is to provide guidance on the procedure for lodging an appeal against a decision made by the NEMLC regarding a medicine.
The objective of the policy is to provide a transparent and equitable method for an appeal to a NEMLC decision in the development of the National Standard Treatment
Guidelines (STGs) and Essential Medicines List (EML), based on fair and evidence-based medicine principles.
The document provides details relating to the grounds on which an appeal may be lodged, the constitution of an Appeal Panel, the process to be followed in lodging an
appeal, the consideration of an appeal and communication of the outcome of such an appeal. Standardised templates to be used are also provided. The policy does not apply to documents produced during the review process or requests for corrections of minor factual or typographical errors. These requests will be reviewed during the standard STG and EML review process.